A changing landscape: Alzheimer’s disease, research and the future of care
Ongoing international research led by Washington University investigators is changing the Alzheimer’s disease landscape from hopeless to hopeful.
Ongoing international research led by Washington University investigators is changing the Alzheimer’s disease landscape from hopeless to hopeful.
Washington University School of Medicine in St. Louis has received a $4.3 million award from the Alzheimer’s Association to expand a major international clinical trial evaluating whether drugs can prevent Alzheimer’s disease in patients genetically predisposed to develop the devastating disease at a young age.